SCHEMBL6284919

SCHEMBL6284919

O=Cc1n[nH]c2cccc(C(=O)O)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.43
HSD17B10 Q99714 2/20 0.41
KDM4E B2RXH2 3/20 0.38
HPGD P15428 1/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 2/20 0.38
ALOX15 P16050 1/20 0.38
MAP2K4 P45985 3/20 0.37
MAPK1 P28482 2/20 0.37
DHODH Q02127 1/20 0.37
MAPKAPK3 Q16644 1/20 0.37
MAPK6 Q16659 1/20 0.37
NAPRT Q6XQN6 2/20 0.37
PBRM1 Q86U86 2/20 0.36
LMNA P02545 2/20 0.36
HCAR2 Q8TDS4 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDR P35968 2/20 0.36
RAB9A P51151 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29954027 1.00 PARP1 (0.43) PARP1HSD17B10KDM4EHPGDALDH1A1
SCHEMBL700007 0.81 KDM4E (0.47) HSD17B10KDM4EALDH1A1LMNARAB9A
SCHEMBL13987127 0.81 MAP2K4 (0.37) HSD17B10KDM4EALDH1A1CYP1A2MAP2K4
SCHEMBL29955478 0.79 IMPDH2 (0.38) PARP1HSD17B10KDM4EALDH1A1CYP1A2
SCHEMBL28497966 0.79 PARP1 (0.45) PARP1HSD17B10KDM4EHPGDALDH1A1
SCHEMBL2019158 0.78 GAA (0.54) PARP1KDM4ENAPRTKDRPLK4
SCHEMBL28503102 0.78 PARP1 (0.44) PARP1HSD17B10KDM4EHPGDALDH1A1
SCHEMBL29955303 0.77 CYP2A6 (0.39) HSD17B10KDM4EALDH1A1CYP1A2MAP2K4
SCHEMBL3535995 0.77 CYP2A6 (0.39) HSD17B10KDM4EALDH1A1CYP1A2MAP2K4
SCHEMBL29956256 0.76 MAP2K4 (0.37) HSD17B10KDM4EHPGDALDH1A1MAP2K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6891044-B2 Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use AGOURON PHARMACEUTICALS, INC. (US) 2005-05-10 US disclosed